Status
Conditions
Treatments
About
Radical gastrectomy has been known as the most effective treatment of curable gastric cancer.However, there is a high risk of malnutrition and weight loss after a gastrectomy which may be attributed to inadequate oral consumption, malabsorption and loss of the reservoir function of the stomach.Weight loss has been regarded as an independent risk factor for postoperative mortality and morbidity and It is also closely associated with a quality of life after surgery. No specific surgical technique has been proved to be effective in reducing postoperative weight loss and it seems like that dietary education and consultation is the best way to minimize weight loss in gastrectomy patients in clinical setting. In this regard, the investigators performed a retrospective pilot study to identify the effect of routinely performed (simplified) dietary education on nutritional status after gastrectomy, but it revealed that the effect of simplified dietary education on weight loss was not clear and the result implies that more intensive dietary education may be necessary after gastrectomy. The aim of this randomized controlled trial (RCT) is to elucidate the effect of intensive dietary education on nutritional status after gastrectomy in comparison with simplified dietary education.
Full description
Subject 1: subtotal gastrectomy group
subject 2: total gastrectomy group
Objectives:
Primary objective: to evaluate Weight loss difference of simplified dietary education(SE) versus intensive dietary education(IE) for patients after undergoing a gastrectomy
Primary endpoint: Superiority of weight loss difference (%) of IE group between post op 1mo and 12mo
Secondary objectives:
weight loss(%) of each subgroup, nutritional parameters (PG-SGA), Calrorie intake & dietary habits, albumin, hemoglobin, iron panel (TIBC, ferritin), Absolute lymphocyte count(ALC), vit B12, homocysteine, quality of life(QOL) change
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
histologically proven primary gastric adenocarcinoma,
T1N0, T1N1, T2N0, which are assessed by computed tomography (CT) scan (AJCC 8th classification) and intraoperative surgical staging
location of primary tumor; antrum, or angle, , lower body or mid body of the stomach
No evidence of other distant metastasis,
age ≥ 20 year old, ≤ 75 year old
no prior or posterior treatment of chemotherapy or radiation therapy against any other malignancies
adequate organ functions defined as indicated below:
written signed informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
358 participants in 4 patient groups
Loading...
Central trial contact
Aron Lee, RD; Jae-Moon Bae, MD, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal